India Strengthens Surveillance to Prohibit the Sales of Health Supplement and Nutraceutical Products Containing PABA

As revealed by the FSSAI notice ^[1] released on July 16th, 2020, India authorities are intensifying the surveillance and enforcement to prohibit the manufacturing and sales, including the sales on e-commerce platforms, of health supplement and nutraceutical products containing PABA (Para Amino Benzoic Acid). Any products containing such ingredient which is already exported to India shall be withdrawn from the market immediately.